How to Interpret a Functional or Motility Test - Colon Transit Study by Kim, Eun Ran & Rhee, Poong-Lyul
JNM Journal of Neurogastroenterology and Motility 
How to Interpret
a Functional or
Motility Test
J Neurogastroenterol Motil,  Vol. 18  No. 1   January,  2012 
pISSN: 2093-0879   eISSN: 2093-0887
http://dx.doi.org/10.5056/jnm.2012.18.1.94
ⓒ 2012 The Korean Society of Neurogastroenterology and Motility
J Neurogastroenterol Motil,  Vol. 18  No. 1   January,  2012
www.jnmjournal.org
94
How to Interpret a Functional or Motility Test - 
Colon Transit Study
Eun Ran Kim and Poong-Lyul Rhee*
Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
ㅋ
Measurement of colon transit time is the most basic and primary tool in evaluating disorders of colonic motility. In particular, 
it is helpful in pathologic diagnosis and for planning management in patients with constipation. Several techniques for meas-
uring colon transit time currently exist. The standard measurement of colon transit time has been performed using radio-
opaque marker test. The radioopaque marker test is the most widely used method; it is simple to perform as well as being 
cost effective. But, this technique produces radiation exposure. Radionuclide scintigraphy and wireless motility capsules are oth-
er techniques used to measure colon transit time. In radionuclide scintigraphy, the transit of radioisotope is viewed by gamma 
camera; this approach has an advantage in that it uses minimal radiation and it allows a physiological assessment of gastro-
intestinal transit. Wireless motility capsules have been validated most recently, but this technique is not useful in Korea. This 
review presents the techniques used to measure colon transit time and the interpretations provided in different colon transit 
studies.
(J Neurogastroenterol Motil 2012;18:94-99)
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Introduction
Colonic motility is a critical process underlying the major 
functions of the large bowel such as storage, absorption, pro-
pulsion and defecation.
1 Disorders of colonic motility typically 
present with constipation or diarrhea. Measurement of colonic 
transit time is useful in evaluating colonic motility, and allows 
both the severity of the problem and the response to therapy to be 
assessed.
Different methods exist to investigate colon transit time. The 
standard measurement of colonic transit time has been performed 
with radioopaque markers or colonic scintigraphy. The tradi-
tional approach is to assess the progression time of radioopaque 
markers along the large bowel.
2 Colonic scintigraphy can evaluate 
whole-gut transit. Recently, wireless motility capsules have also 
been validated as a technique in measuring colon transit time.
Radioopaque Markers
Assessment of colon transit based on ingested radioopaque 
markers has been widely adopted since Hinton et al
3 first de-
scribed this technique in 1969. Radioopaque marker testing dis-
tinguishes constipation subgroup such as normal or slow transit Colon Transit Study
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Figure 1. Colonic segments in abdominal X-ray. Spinal processes and 
imaginary lines from fifth lumbar vertebra to right pelvic outlet and left
iliac crest, serving as landmarks defined projection zones of right, left 
and rectosigmoid colon. R, right colon; L, left colon; RS, rectosigmoid
colon.
Table. Colon Transit Times Measured Using Radioopaque Markers in Healthy Korean Adults
7,18,20-22,24
Author
X-ray 
on day
Number
Age (mean ± SD 
or range, yr)
Colon transit time (mean ± SD or median [range], hr)
Total colon Right colon Left colon RS colon
Koo et al,
22 1991 4     28 22.4 ± 4.9   8.7 ± 4.2     9.8 ± 4.3   3.9 ± 4.8
Bak et al,
21 1996 7     32 (m = 5)      40-54 24 (1.7-32.4) 4.8 (1.2-7.2) 3.6 (0.0-20.4) 0.0 (0.0-7.2)
Kim et al,
7 2001 4, 7     30 (m = 15) 43.3 ± 13.2 30.3 ± 14.9
Lee,
24 2010 4, 7     75 (m = 35) 41.9 ± 13.7 20.5 ± 20.3   5.4 ± 7.2     7.6 ± 11.0   7.7 ± 12.1
Kim et al,
20 2003 4, 7     15 (m = 11) 50.2 ± 1.5 24.0 ± 4.1 6.88 ± 1.17 10.80 ± 2.59 4.96 ± 1.19
Jung et al,
18 2003 4, 7     42     34 ± 7 26.5 ± 19.4   5.9 ± 6.9     9.2 ± 9.2 11.5 ± 11.1
m = 21    35 ± 7 22.3 ± 16.1   5.9 ± 7.7     6.0 ± 6.1   5.9 ± 7.7
  f = 21    34 ± 8 30.1 ± 21.4   5.8 ± 6.2   12.5 ± 10.7   5.7 ± 6.2
RS, rectosigmoid; m, male; f, female.
constipation, and assesses segmental transit times in patients with 
delayed total colon transit.
4 This test is simple and inexpensive as 
well as reliable and reproducible. However it requires good com-
pliance of the patient, produces radiation exposure, and does not 
measure the transit of a physiological meal.
5,6
Methods
Radioopaque markers are plastic beads or rings that are usu-
ally ingested in a capsule containing 20-50 markers. Two kind of 
radioopaue markers, Sitzmarks
Ⓡ (Konsyl Pharmaceuticals, Texas, 
USA) and Kolomark
TM (M.I.Tech., Pyongtaik, Korea)
7,8 is 
commonly used in Korea. Each single capsule contains 24 or 20 
radioopaque markers, respectively. 
Several methods have been suggested when it comes to using 
radioopaque markers, including the single capsule technique and 
the multiple capsules technique.
9,10 The single capsule technique 
requires ingestion of markers in a single capsule on a specific day, 
followed by several abdominal X-rays that are repeated until all 
markers are defecated or a single abdominal X-ray on day 5 (120 
hours later). However the “single ingestion with multiple X-ray” 
technique is time-consuming and produces greater radiation 
exposure. The multiple capsules technique requires the ingestion 
of 1 capsule a day for 3 days, followed by abdominal X-rays on 
day 4 and 7 or only on day 7.
Interpretation
Interpretation is based on the identification of markers in 3 
regions namely the right, left and rectosigmoid regions. These are 
defined by bony landmarks and gaseous outlines as described by 
Arhan et al
11 (Fig. 1).
In the single capsule technique with a single abdominal X-ray 
on day 5 (120 hours later), delayed transit is defined as ＞ 20% re-
tention of markers. Evans et al
12 measured the time taken for ra-
dioopaque markers to pass through the large bowel in 25 healthy 
men and 18 healthy women. They demonstrated that 95% of nor-
mal subjects pass more than 80% of markers within 120 hours.
In the multiple capsule technique, colon transit times in each 
segment and through the entire colon are calculated by multi-
plying the number of markers by 1.2 (or by 1.0 when using a cap-
sule containing 24 markers).
13
Normative data for colon transit time in adults are available 
from a large number of radioopaque markers studies.
10,14-17 In 
most such studies from western, the mean colon transit time was Eun Ran Kim and Poong-Lyul Rhee
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Figure 2. Method of measuring colonic
transit: radioisotope-labeled activated 
charcoal particles delivered in a pH- 
sensitive methacrylate-coated capsule to 
the ileocolonic region. Methacrylate 
dissolves at pH ＞ 6.4, which is achieved
in the terminal ileum. The radiolabeled 
particles traverse the colon in the stool, 
and the counts in each of 5 regions are 
used to summarize the location of the 
weighted average or geometric center at 
specified times after capsule ingestion 
(eg, at 24 and 48 hours).
26
30-40 hours, with upper normal limit of 70 hours in mixed 
populations. However, there were differences in colon transit 
times between studies due to differences in age, gender ratio, race 
and methodology. Women had a longer maximal colon transit 
time compared with men.
4,15,16,18 In women, menstral cycle influ-
enced colon transit times.
15,18
Also, colon transit times are generally shorter in normal 
Asian populations than in Westerners. In studies from Korea, 
mean colon transit time was 20-30 hours in normal subjects 
(Table).
7,18-22 Moreover, Chan et al
23 found that the colon transit 
time was 24.5 ± 18.8 hours (21 hours in men and 28 hours in 
women) in healthy Chinese adults. Despite the current lack of a 
direct comparative study of Asian and Westerners, dietary differ-
ences may make a difference in colon transit time between Asian 
and Westerner.
24 Consumption of fiber or spicy foods may be 
higher in Asian compared to Western populations.
Colonic Transit Scintigraphy
The utilization of a radionuclide to measure gut transit was 
first demonstrated by Krevsky et al
25 in 1986 using cecal intu-
bation. The scintigraphic technique use minimal radiation and 
has been shown to be a reliable alternative for accurate quantita-
tive measurement of colonic transit. In addition, the test offers re-
producible and accurate performance across a spectrum of com-
mon colonic motility disorders, linking colonic transit measure-
ments to biological processes, and provides correct prediction of 
outcomes in therapeutic interventions.
26 Therefore, this test is in-
dicated to measure whole-gut and regional colonic transit in pa-
tients with suspected colonic motility disorders or more diffuse 
disorders involving the stomach and small bowel.
4
On the other hand, scintigraphy studies are very long in du-
ration making them impractical for many nuclear medicine 
departments.
6
Methods
Scintigraphy transit tests involve the ingestion of radioactive 
isotopes, where their progression through the gastrointestinal 
tract is followed with a large-field-view gamma camera (Fig. 2). 
The test uses the long half-life radionuclides 
111indium. There are 
2 methods for the delivery of markers in clinical uses: 
111indium- 
diethylenetriamine pentaacetic acid (
111In-DTPA) labeled water 
consumed in a standard solid-liquid meal
27,28 and 
111indium/acti-
vated charcoal slurry contained within a pH-sensitive polymer 
methacrylate- coated capsule designed to break down in the alka-
line environment of terminal ileum and release the radioisotope 
into the lumen.
9,29 A shorter half-life isotope, technetium 99m, 
can be added to measure gastric and small bowel transit. In prac-
tice, one should image the colon at 24 and 48 hours to identify 
patterns of transit different from normal.
30
Interpretation
Studies use many different reporting modes including transit 
time in hours (T1/2), percentage of radioactivity retained, prox-
imal colonic emptying or center of mass.
10
Generally, 2 end points are used to summarize colonic trans-Colon Transit Study
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Figure 3. Wireless motility capsule: this
figure displays wireless motility capsule 
profiles from healthy subject who had 
normal colon transit time as well as 
normal gastric emptying time. GET, 
gastric emptying time; SBTT, small 
bowel transit time; CTT, colon transit 
time.
it: (1) overall colon transit, expressed as geometric center; and (2) 
emptying of the ascending colon.
4,26
The colon can be divided into 5 or 7 regions of interest. The 
5 regions-of-interest program is commonly used to quantitate 
counts in each colonic segment: ascending colon (AC), transverse 
colon (TC), descending colon (DC) and rectosigmoid (RS), 
numbered as segments 1-4, respectively. Segment 5 refers to ex-
pelled stool (S).
4,26,31
The geometric center (GC) is the weighted average of the 
isotope distribution within colon and stool. The GC is expressed 
as the sum of the multiplication of the proportion of 
111In counts 
in each colonic segment at a given time by that segment’s weight-
ing factor
32: 
GC = [(%AC × 1) + (%TC × 2) + (%DC × 3) + (%RS 
× 4) + (%S × 5)]/100
A high GC implies fast colonic transit because the center of 
the activity has progressed to the left side of the colon or has been 
eliminated in the stool, whereas a low GC implies slow colonic 
transit because the center of the activity is in the proximal 
colon.
26,32
Maurer et al
30 determined that using solid-liquid meal, the 
normal mean (± 1 SD) GC values were 4.6 ± 1.5 at 24 hours 
and 6.1 ± 1.0 at 48 hours in a recent update based on their expe-
rience and previous studies.
10,33
The emptying of the AC is summarized as the T1/2 (time for 
50% emptying) as calculated by linear interpolation of values on 
the AC emptying curve.
26 The measurement of proximal colon 
emptying with GC can be useful in the differentiation of patients 
with slow colonic transit and pelvic outlet obstruction.
34
Wireless Motility Capsule
A wireless motility capsule system (SmartPill GI Monitoring 
System, The SmartPill Corporation, Buffalo, NY, USA) was ap-
proved by the Food and Drug Administration in 2006 for the as-
sessment of gastric emptying and whole gut transit time.
35
The wireless motility capsule (WMC) test is well tolerated, 
exhibit good compliance and measures colon transit time without 
radiation exposure.
4 Therefore, the WMC test has potential to be 
a useful diagnostic test to evaluate patients for gastrointestinal 
transit disorders and to study for colonic responsiveness to phar-
macologic agents.
However, although a few studies showed a moderately strong 
correlation between the WMC test and radioopaque markers 
study for colon transit,
36 there is not enough evidences about the 
availability of the WMC test for measuring colon transit time, 
currently. In addition, it is expensive, requires physician training 
for interpretation and device failure is reported in ∼3% of cases.
4 
Above all, the WMC test is not available in Korea.
Methods
The WMC system consists of a wireless ingestible motility 
capsule, a portable data receiver worn by the patients for acquir-
ing data, and data analysis software (MotiliGI; SmartPill Corpo-
ration, Buffalo, NY, USA). The WMC system houses sensors 
for pH, temperature and pressure, and has the ability to transmit 
the sensed data at 434 MHz. The shape and dimensions of the 
WMC system (cylindrical, 26.8 mm long by 13 mm in diameter) 
are similar to those of pill endoscopy. The system’s MotiliGI 
software provides calculations and graphical displays of the data Eun Ran Kim and Poong-Lyul Rhee
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( F i g .  3 ) .  D a t a  c a n  b e  r e v i e w e d  i n  r e a l  t i m e  o r  a f t e r  s t u d y  
completion.
6,36 The WMC system’s battery lasts for at least 5 
days after activation.
6 The capsule measures pH (range, 0.05-9.00 
pH units), pressure (range, 0-350 mmHg) and temperature 
(range, 25-49
oC).
36
Interpretation
Whole gut transit is defined as the interval between capsule 
ingestion and its exit from the body.
6 The capsule exit time is 
verified by a loss of signal and/or abrupt drop in temperature.
Capsule gastric emptying time is defined as the duration of 
the time from WMC ingestion to pyloric passage, as determined 
by an abrupt ≥ 2 pH unit increase from the lowest postprandial 
value to at least 4 that does not decrease below 4 for ＞ 10 mi-
nutes at any subsequent time.
37,38 Small bowel transit time is de-
fined as the time interval between capsule entry into the small 
bowel and its entry into the cecum. The cecal entry is defined as a 
distinct drop of more than 1 pH unit that is sustained for more 
than 10 minutes and occurs at least 30 minutes after capsule entry 
into the small bowel.
37,39
Delayed gastric emptying is diagnosed when the emptying 
time exceeds 5 hours (range: 2 to 5 hours). Delayed small in-
testinal transit is determined when transit times exceed 6 hours 
(range: 2 to 6 hours), based on 95% cutoff values from control 
studies. Delayed colon transit is diagnosed when transit times ex-
ceed 59 hours (range: 10 to 59 hours).
36-39
Conclusion
Assessment of colon transit is important in patients with 
symptoms of colonic dysmotility because it can provide useful 
mechanistic insights and demonstrate response to treatment. 
Until now, a variety tests have been available for measuring colon 
transit. Radioopaque marker tests have traditionally been per-
formed to measure colon transit time and this technique is the 
most widely used method to date. Recently, the colonic scintig-
raphy and the WMC test have been validated for measuring 
whole gut transit as well as colon transit. However, the colonic 
scintigraphy is used less frequently in clinical practice and the 
WMC test is not available in Korea.
Therefore, radioopaque marker test is clinically useful for the 
detection of altered colon transit in Korea. It is also important to 
perform the colon transit study considering clinical purpose and 
patient’s condition.
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